Literature DB >> 6631061

Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

J M Vergeront, S J Stolz, B A Crass, D B Nelson, J P Davis, M S Bergdoll.   

Abstract

Staphylococcal enterotoxin F (SEF) has previously been shown to be a marker for toxic-shock syndrome (TSS)-associated strains of Staphylococcus aureus, whereas the serologic absence of antibody to SEF (anti-SEF) has been shown to be a marker for susceptibility of persons to TSS. In this study, anti-SEF was measured by radioimmunoassay in 689 banked sera obtained from Wisconsin residents during 1960, 1970, and 1980. The prevalence of anti-SEF as estimated by logistic regression analysis was 47%, 58%, 70%, 88%, 96%, and 99% at ages one, five, 10, 20, 30, and 50 years, respectively. Evidence for the transplacental transfer of anti-SEF is also presented. Despite the reported increased incidence of TSS occurring during the past five years, with a preponderance of cases occurring among women, no significant differences in the prevalence of anti-SEF were noted between sexes or longitudinally between the years 1960, 1970, and 1980. These data enhance our understanding of the epidemiology of TSS and further identify the population that may be susceptible to TSS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631061     DOI: 10.1093/infdis/148.4.692

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.

Authors:  F J Schmitz; C R MacKenzie; R Geisel; S Wagner; H Idel; J Verhoef; U Hadding; H P Heinz
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

3.  Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.

Authors:  J Valle; S Vadillo; S Piriz; E Gomez-Lucia
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

4.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

5.  Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates.

Authors:  John E Warner; Andrew B Onderdonk
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

6.  Reemergence of staphylococcal toxic shock syndrome in the United States since 2000.

Authors:  Philip M Tierno
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards.

Authors:  Ken Kikuchi; Naoto Takahashi; Chuncheng Piao; Kyoichi Totsuka; Hiroshi Nishida; Takehiko Uchiyama
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.

Authors:  M F Hofer; K Newell; R C Duke; P M Schlievert; J H Freed; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.